A pharmacy law decision often turns on several facts at once: who is acting, what drug is involved, where the transaction occurs, and which record must support it. This guide is organized around those decisions for a pharmacist seeking licensure in Guam. It begins with professional authority and supervision, then follows an order from prescribing through patient care and dispensing. The final section covers the pharmacy systems that make each transaction lawful and traceable. Worked scenarios will ask you to identify the controlling question, resolve conflicting facts, and explain the result. For a controlled substance, for example, a valid prescriber and a complete prescription still leave the pharmacist responsible for evaluating whether dispensing is appropriate.
Licensure/Personnel
1. Who may practice pharmacy
When a patient asks for a professional assessment, start with the person's authority, then the task. A Guam pharmacist's license supports independent pharmacy judgment within the pharmacist's scope. An intern's registration supports supervised learning and assigned pharmacy work; it is a step toward licensure, not a substitute for it. A technician may perform authorized support tasks under the applicable supervision conditions, but cannot make a clinical decision merely because the task involves a prescription. The distinction turns on what the person must decide. Entering a drug name is technical work; deciding whether that drug is appropriate for a patient requires evaluation of therapy, risks, and alternatives. Guam's pharmacy definitions describe pharmacist practice and intern status. For any proposed assignment, identify the credential, the permitted task, the available supervision, and who makes the final professional decision.
Worked example: A patient asks a licensed pharmacist, a registered intern, and a technician whether a newly prescribed drug is suitable alongside an existing medicine. The technician can gather the medication list. The intern can review it as an assigned, supervised learning task. The pharmacist evaluates the interaction, decides whether clarification is needed, and gives the patient the clinical answer. All three contributed, but only the pharmacist exercised independent professional judgment.
Watch the distinction: Registration as an intern or technician does not create pharmacist authority. Experience with a task may improve performance, but it does not change who may make the clinical decision.
2. Managing pharmacist and pharmacist in charge
Responsibility for directing a pharmacy and responsibility during a particular shift answer different questions. Guam's rules define the managing pharmacist as the pharmacist designated by the owner to control pharmaceutical operations. They define the pharmacist in charge as the pharmacist physically present and responsible for routine operation during an assigned period. First identify the owner's designation; that tells you who has the continuing management role. Then identify who is present and assigned when the event occurs; that tells you who is directing routine work at that time. A shift pharmacist should address an immediate safety problem rather than wait for the manager's return. The manager's broader duties still matter for systems such as staffing, records, and securing the professional service area. The labels therefore track both an ongoing operational responsibility and responsibility during actual coverage.
Worked example: An owner designates Mira to direct pharmacy operations. Mira works mornings; Jonah covers Tuesday evening and is physically present. When a technician finds an unlabeled bottle that evening, Jonah controls its immediate handling and investigates before use. Mira remains the designated managing pharmacist and should receive the information needed to address a recurring storage problem. Jonah's shift responsibility does not silently transfer the owner's designation.
Watch the distinction: The pharmacist on duty is not automatically the managing pharmacist. Conversely, a manager who is away does not replace the present pharmacist's responsibility for routine operations during that shift.
3. The pharmacist's final judgment
A support worker can gather accurate information and still leave the decisive safety question unresolved. The pharmacist's review connects the order, patient profile, drug, directions, and prepared product. Look for facts that require interpretation: an allergy, unusual dose, duplicate therapy, unclear directions, or a mismatch between the order and stock. The pharmacist must decide whether the concern is clinically meaningful, obtain clarification when needed, and determine whether dispensing may proceed. The final product check then asks whether the selected medicine, strength, dosage form, quantity, and label match the verified order. These are linked steps: a perfectly counted bottle can still be unsafe if the therapy was never assessed. Delegating data entry or preparation does not delegate responsibility for the professional evaluation that authorizes release.
Worked example: A technician enters an antibiotic order and selects the correct bottle. The profile records a prior severe reaction to that drug. The pharmacist pauses release, clarifies what happened, and contacts the prescriber if the documented reaction is credible. If the prescriber changes therapy, the pharmacist verifies the replacement order, product, and label. The technician's correct stock selection did not resolve the allergy.
Watch the distinction: A pharmacist's final check is more than comparing the label with the bottle. Matching text cannot establish that the medicine is safe for this patient's documented history.
4. Technician work and supervision
Classify a technician task by the judgment it demands. Counting, packaging, entering supplied information, and preparing a label can be technical steps when performed within the technician's authorization and required supervision. Choosing therapy, interpreting an ambiguous order, assessing an interaction, or deciding whether a patient can safely use a drug calls for pharmacist judgment. A useful sequence is to identify the act, check the worker's credential and allowed duties, confirm the supervising pharmacist is available as required, and reserve professional review before release. A question may begin as routine data collection and turn clinical when new facts appear. The technician should preserve the patient's question accurately and bring it to the pharmacist instead of guessing. Supervision is active control of the delegated workflow, not a way to convert every pharmacy task into technician work.
Worked example: Under appropriate supervision, a technician enters an order for medicine A and prepares its label. At pickup, the patient asks whether medicine A can be taken with medicine B. The technician records the names and sends the question to the pharmacist. The pharmacist checks the patient's regimen, evaluates the combination, and explains the plan. Label preparation was technical; the interaction assessment was professional.
Watch the distinction: A familiar question is not automatically a technical task. Even if a technician has heard the pharmacist answer similar questions, patient-specific interaction advice still needs pharmacist evaluation.
5. Intern authority
An intern's authority depends on both status and circumstances. Guam's rules describe an intern as a person registered for practical experience toward pharmacist licensure. A training assignment should therefore be assessed by checking current intern status, the task's place in authorized experience, the identity and availability of the supervising pharmacist, and any limits on that task. Supervised participation can include meaningful patient care and clinical reasoning; it remains supervised participation. If the required supervision is unavailable, an intern cannot fill the gap by acting as the independent pharmacist. This matters especially when a conversation changes from explaining prepared information to judging a patient's treatment. Record the work and supervision accurately so the experience demonstrates what the intern actually did. The patient should receive a decision from someone with authority to make it.
Worked example: An intern has prepared to counsel a patient about a new inhaler, but the supervising pharmacist has left and no qualifying replacement is available. The intern does not conduct independent counseling. Staff arrange for an authorized pharmacist to provide the service, and the intern participates later if supervision is restored. The intern's preparation and registration do not supply the missing supervision.
Watch the distinction: Being close to graduation does not make an intern a pharmacist. Authority follows the current credential and applicable supervision conditions, even when the intern understands the clinical material.
6. Documenting practical experience
Practical experience must be both accumulated and evidenced. Guam's pharmacist examination application calls for certification of 1,500 hours under a registered pharmacist preceptor. Track actual dates, hours, site, and supervisor so the total can be checked and duplicate or unsupported time can be found. Then separate three questions: Were the hours performed? Can the preceptor truthfully certify the work and supervision? Will the Board accept the submitted experience toward licensure? A signed form answers the second question; it does not decide the third for the Board. The supplied Guam rules also address internship reports and changes in experience area, so a candidate should preserve records when placements or preceptors change. Arithmetic establishes a claimed total, while documentation and Board review establish whether that claim counts.
Worked example: A candidate has 1,320 documented hours and completes another 180 under a registered pharmacist preceptor. The arithmetic is 1,320 hours + 180 hours = 1,500 hours, matching the total stated in Guam's application. The candidate still needs accurate dates and preceptor certification. The Board must review the submission before the candidate treats those hours as accepted licensure experience.
Watch the distinction: Reaching 1,500 on a personal spreadsheet is not Board acceptance. Hours that lack credible supervision or documentation may fail review despite a mathematically correct total.
7. Licensure by examination
Licensure by examination is a sequence of separate decisions. The candidate assembles the application and required evidence, including pharmacy education and practical experience. The Guam Board reviews prerequisites and confirms examination eligibility. The applicant then completes the examinations required for the route, and the Board determines whether the full licensure conditions have been met. The application identifies both NAPLEX and the Guam MPJE and states that eligibility requires Board confirmation. Passing one examination proves performance on that examination; it neither confirms eligibility for the other nor grants a Guam pharmacist license. When solving a status question, place each fact on a timeline: application filed, evidence received, eligibility confirmed, examinations passed, license issued, and license currently active. The authority to practice follows the operative credential, not an expected future result.
Worked example: Leah has graduated, submitted an application, and passed NAPLEX through another jurisdiction. She has no Board confirmation that she may sit for the Guam MPJE and no Guam pharmacist license. Her NAPLEX result is relevant evidence, but she cannot assume MPJE eligibility or practice independently. She completes the outstanding application review and waits for the Board's licensure decision.
Watch the distinction: Passing NAPLEX is not the same event as receiving a Guam license. Even completed examinations leave the Board's prerequisite review and issuance decision to be resolved.
8. Foreign graduate documentation
A foreign pharmacy graduate may need evidence that addresses the education pathway before the ordinary licensure decision can be completed. Guam's application asks foreign graduates for a Foreign Pharmacy Graduate Examination Committee certificate issued by NABP and asks the Board to verify the related examination information. Treat that credential as documentation of the foreign graduate step. It is not a Guam pharmacist license, an exemption from practical experience, or proof that both licensure examinations are complete. Work through the file by identifying the applicant's education route, the foreign graduate evidence requested, the remaining application materials, Board-confirmed examination eligibility, examination results, and final license status. This sequence prevents one certificate from being mistaken for an all-purpose approval. The Board, rather than the applicant's possession of a document, decides whether the submitted evidence meets its licensure requirements.
Worked example: Ravi presents an FPGEC certificate with his Guam application. It supports the foreign graduate documentation portion of his file. He still supplies the other applicable education and experience evidence, obtains Board confirmation of examination eligibility, completes the required examinations, and awaits the Board's licensure decision. Until an appropriate Guam credential is issued, the certificate alone gives him no independent practice authority.
Watch the distinction: An FPGEC certificate is not portable pharmacist licensure. It addresses a particular credential review step and cannot stand in for Guam's examination, application, and licensing decisions.
9. Licensure routes and license status
A license held elsewhere and a license to practice in Guam are different legal facts. An examination applicant uses education, experience, and exam evidence for Board review. A pharmacist already licensed in another jurisdiction may have an applicable recognition or transfer route, but must satisfy that route's conditions and receive Guam authority before practicing there. Start by identifying the proposed route, then distinguish evidence supplied to support an application from the credential that actually authorizes the work. Also check the present status of any license: active, expired, restricted, suspended, or otherwise limited. A prior credential may be relevant to qualifications or discipline history without being valid authority at a Guam site. Guam's application asks applicants to list pharmacist and intern licenses held in other jurisdictions, which supports review of that history, not automatic conversion of those licenses.
Worked example: Nora has an active pharmacist license in another state and sends its details with a Guam application. The license demonstrates prior licensure for the Board to evaluate. It does not permit her to cover a Guam pharmacy shift that afternoon. She may practice independently in Guam only after an applicable Guam authorization is granted and remains active for the work proposed.
Watch the distinction: An active out-of-jurisdiction license is evidence of status there, not permission to practice everywhere. The relevant Guam credential and its current conditions control work in Guam.
10. Renewal and continuing education
Continuing education and renewal work together, but they perform different jobs. Education documents maintenance of professional knowledge; renewal is the process that keeps a license in force under the applicable requirements. To evaluate a pharmacist's authority on a particular day, check the license's current status first, then determine whether renewal, continuing education evidence, or reinstatement is required. A course completion record cannot by itself revive an expired license. Likewise, paying a fee without satisfying the other renewal conditions should not be treated as proof of active status. Guam's rules address continuing pharmacy education and reinstatement after lapse or discipline, although current requirements must be checked for the relevant period. Keep evidence tied to the reporting period and credential so it can support a valid application rather than become an untraceable list of courses.
Worked example: A pharmacist completes every course she planned for the year, but her Guam license has lapsed. A pharmacy schedules her to verify prescriptions tomorrow. She cannot rely on course certificates as authority to work. The scheduling decision turns on whether the applicable renewal or reinstatement process has been completed and an active authorization is in effect before the shift.
Watch the distinction: Education completion does not automatically renew a license. The decisive fact for independent practice is an active credential with its conditions satisfied, supported by the required documentation.
11. Temporary authority
Temporary authority is a credential with boundaries. Read the authorization itself for the person covered, activities allowed, effective date, expiration date, and any supervision or setting conditions. Then compare the proposed work with those terms. A pending application for full licensure does not extend a temporary credential, and a temporary credential does not silently become unrestricted when an examination is passed. The decision sequence is simple: confirm issuance, confirm the credential is active on the date of work, confirm the proposed task falls within its scope, and check whether an extension or separate license has actually been granted. Guam's application materials list a temporary license category, but that listing does not establish universal eligibility or the terms of a particular authorization. Those terms must be established for the individual case.
Worked example: A pharmacist has a temporary Guam authorization that states it expires on June 30. A full license application remains pending on July 1. For a July 2 shift, the temporary document is past its stated date. The pharmacy needs a valid extension or another active Guam authorization before assigning pharmacist duties; the unresolved application does not cover the gap.
Watch the distinction: Temporary does not mean open ended. A person cannot infer an extension from a pending application, a favorable exam result, or an employer's expectation that approval is imminent.
12. Discipline and due process
Discipline questions require attention to procedural stage and the actual order. A complaint supplies information for possible investigation; an investigation gathers facts; a formal allegation frames a charge; a Board order states an enforceable outcome. These stages should not be collapsed. A complaint alone does not suspend a license, while an issued order may restrict duties, impose conditions, suspend authority, or take another action according to its terms. Read the effective date, person or permit covered, restrictions, duration, and any conditions for return to practice. Due process provides the person a route to respond under the applicable procedures, but a pending challenge should not be assumed to erase an effective restriction. Guam's application asks about previous revocation, suspension, or investigation, which also shows why a disclosure question may reach events with different legal effects.
Worked example: A patient files a complaint against a pharmacist on Monday. On Tuesday, no Board restriction has been issued, so the complaint itself is not a suspension. If a later order limits the pharmacist from handling controlled substances starting Friday, the pharmacy must apply that precise restriction from its effective date. It should not invent broader limits or ignore the stated one.
Watch the distinction: A complaint and a disciplinary order are different records. Treating every allegation as a suspension can misstate authority; ignoring an effective order can permit prohibited practice.
13. Impaired ability to practice
When a pharmacist appears unable to work with reasonable skill and safety, the first decision concerns patients currently exposed to the risk. Stop unsafe verification or release, arrange qualified coverage, and secure unresolved orders so they receive proper review. Next preserve objective observations: what happened, when, which work was affected, and who took over. Avoid diagnosing the cause from appearance alone; fatigue, illness, medication effects, and other conditions can look similar while still requiring an immediate safety response. Then follow the applicable reporting and assistance processes, including any Board or employer obligations. Participation in an assistance pathway may help address the underlying problem, but it does not justify leaving unsafe practice in place while the pathway begins. Keep the response proportionate, factual, and protective of confidentiality.
Worked example: During a shift, a pharmacist repeatedly cannot distinguish verified prescriptions from unfinished ones and appears unable to check them safely. A second qualified pharmacist takes over, separates pending orders, and rechecks anything whose status is uncertain. The supervisor documents the observed failures and handles reporting through the applicable process. The team protects patients without making an unsupported diagnosis about why the pharmacist was impaired.
Watch the distinction: Waiting for proof of a particular illness or substance use can leave patients exposed. The immediate trigger is an observed inability to perform safely, followed by fair fact gathering.
Reference: [1]
Pharmacist Practice
14. Finding the controlling requirement
A pharmacy transaction may be governed by several rules at once. Begin with the actor, drug, setting, and action: who issued the order, what substance it concerns, where it will be dispensed, and whether the act is prescribing, transferring, filling, or administering. Then test each applicable federal and Guam requirement. A federal rule may establish an acceptable form or baseline condition, while Guam law may separately define the prescriber's scope or impose another restriction. Compliance with one requirement does not cure failure of another. The MPJE competency statements identify federal and jurisdictional law as the examination's subject, but the actual decision requires applying the controlling provisions to the facts. When two rules govern the same act, determine whether both can be satisfied and apply the operative restriction for the Guam transaction.
Worked example: A controlled prescription arrives in a federally acceptable electronic form. The issuer's license is valid, but the requested drug is outside that practitioner's authorized Guam scope. The pharmacy cannot dispense merely because the form is valid. The pharmacist verifies the scope issue and seeks an order from a practitioner authorized for that therapy if treatment remains appropriate.
Watch the distinction: A federally compliant prescription form does not establish prescriber authority. Form, professional scope, controlled substance registration, and Guam dispensing conditions must each be satisfied where applicable.
15. Prescriber identity and authority
A prescriber's name and license number identify a possible issuer; they do not answer every authority question. Verify that the order truly came from that practitioner, the credential is valid for the relevant jurisdiction and date, the drug falls within the practitioner's professional scope, and any controlled substance registration required for the drug is valid. A specialist's usual treatment area is a useful contextual clue, but legal scope is determined by applicable authority, not by an informal job title alone. Also distinguish a forged identifier from a real identifier used beyond its authority: both can make an order unacceptable, for different reasons. Resolve uncertainty before dispensing by using reliable records and direct clarification where appropriate. Document what was checked and the conclusion so the decision can be reconstructed.
Worked example: An order displays a valid professional license number, but the medicine requested is outside the issuer's authorized scope for this case. The pharmacist verifies the issuer and the scope limitation, holds the order, and contacts the office for clarification. A second authorized prescriber issues an appropriate order. The original number's validity did not make the first order dispensable.
Watch the distinction: A valid license number is not a universal prescribing permit. The relevant question is whether this practitioner could issue this order for this drug under the applicable conditions.
16. Restrictions tied to a drug's use
Some medicines have conditions tied to their use or distribution beyond ordinary prescription completeness. A drug-specific program may require enrollment, patient qualification, prescriber certification, authorization for a particular fill, or documented counseling. The pharmacist should first confirm the product and indication, then identify which conditions apply to that product and transaction, who must complete them, and what evidence must exist before release. The conditions can change with formulation or use, so an apparently similar product may require a different check. Program approval is separate from clinical assessment: an authorization code does not prove that the dose is safe, and a clinically sound order does not waive a distribution restriction. Record the relevant verification in a way that ties it to the specific patient and fill.
Worked example: A complete prescription arrives for a drug supplied through a restricted distribution program. The patient and prescriber details match, but the required fill authorization has not been documented. The pharmacist verifies the program status, obtains the needed authorization through the approved process, checks the clinical order, and only then releases the drug. Completeness of the prescription alone was insufficient.
Watch the distinction: A drug-specific authorization is neither a general prescribing license nor a substitute for clinical review. Both the program's release conditions and ordinary safety checks still matter.
Reference: [1]
17. A complete noncontrolled order
A noncontrolled prescription must identify the patient, authorized prescriber, drug, quantity, directions, and issue information well enough for an accurate dispensing decision. Guam's definition of a prescription lists these core elements, including prescriber and patient identifying details. Check that each element is present and internally consistent before preparing the final label. An omission may be correctable through a legitimate prescriber clarification, but the pharmacist should distinguish receiving missing information from inventing it. Directions determine how the patient will use the product and how quantity relates to intended duration; they cannot be guessed from a familiar dose. Record the source, date, and substance of any clarification so the completed order reflects what the prescriber actually authorized. A readable order can still require intervention if its content is ambiguous or clinically unsafe.
Worked example: An order for 30 tablets gives the drug and strength but omits directions. The pharmacist contacts the prescriber, who confirms one tablet daily. That makes the stated quantity a 30-day supply if taken as directed: 30 tablets ÷ 1 tablet per day = 30 days. The pharmacist records the clarification, prepares the matching label, and completes the safety review before dispensing.
Watch the distinction: A common dosing pattern is not prescriber authorization. If directions are missing, calculating a plausible days' supply cannot replace obtaining and documenting the intended instructions.
18. Controlled substance order elements
For a controlled substance order, combine ordinary prescription checks with schedule and prescriber authority. Identify the exact drug and schedule first, because schedule affects issuance, refills, and other handling rules. Confirm the patient's and prescriber's identifying information, the drug and directions, the issue date, and the prescriber's authority to issue controlled prescriptions in the relevant jurisdiction. A registration identifier should be checked as part of a broader authority inquiry; a number printed on a form is not proof that it is valid or belongs to the issuer. If an element is missing or contradictory, determine whether clarification is legally permitted for that element before changing the record. The related MPJE study guide can help place schedule rules in the wider federal framework; apply Guam requirements to the actual fill.
Worked example: A controlled prescription contains the patient's details, drug, quantity, and directions, but its listed prescriber registration does not validate. The pharmacist holds the order, verifies the practitioner's identity and controlled substance authority, and checks whether the problem is a transcription error or lack of authorization. Dispensing proceeds only if the order can be established as valid under the applicable rules.
Watch the distinction: Complete patient and drug fields do not rescue an unauthorized controlled prescription. The pharmacist must resolve prescriber identity and controlled substance authority before treating the order as valid.
19. Schedule II issuance and emergency orders
Schedule II prescriptions generally use the permitted written or electronic issuance pathway. Federal law provides a narrow emergency oral pathway when immediate administration is necessary, no appropriate alternative is available, and the time needed for the usual issuance method cannot be allowed. The pharmacist must evaluate those conditions from the facts, rather than accept the word “emergency” as a conclusion. When the pathway applies, the oral order is limited to the amount needed for the emergency period, the pharmacist documents the required order information, and the prescriber must provide the required follow-up prescription within the applicable federal period. Additional Guam conditions may also matter. A routine request to continue a chronic therapy, even if urgent to the patient, should be separated from the specific legal emergency conditions. The decision should be documented so the basis and follow-up can be traced.
Worked example: A caller requests another fill of a patient's Schedule II medicine and calls it an emergency because the patient is leaving town tomorrow. The pharmacist asks whether immediate administration is necessary, whether an appropriate alternative exists, and whether there is time for an ordinary valid prescription. On these facts, travel alone does not establish the emergency pathway; the pharmacist requests a properly issued new prescription.
Watch the distinction: Urgency and legal emergency are not synonyms. A prescriber or caller cannot turn an ordinary Schedule II refill request into an emergency oral order merely by using that label.
Reference: [1]
20. Controlled refills by schedule
Refill authority starts with the drug's schedule. Federal law prohibits refilling a Schedule II prescription, even if the written order claims to authorize refills. For Schedules III and IV, federal law permits refills only within its count and time limits when the prescriber authorized them; Schedule V also requires valid prescriber authority and applicable federal and Guam conditions. Check the original prescription, schedule, remaining authorized refills, issuance and dispensing history, and any stricter applicable restriction. A new prescription is a distinct authorization, not a way to relabel an exhausted refill. Likewise, partial dispensing has its own rules and should not be mistaken for a refill. In Guam MPJE practice questions, work the schedule classification before interpreting any refill notation.
Worked example: A Schedule II prescription says “three refills.” The pharmacist dispenses the initial fill only if the order otherwise qualifies. A later request cannot be supplied as refill one: federal Schedule II rules prohibit refills regardless of the notation. If continued treatment is appropriate, the patient needs a new valid prescription from an authorized prescriber, subject to the usual review.
Watch the distinction: A prescriber's refill notation cannot override the drug's schedule. Read schedule restrictions before counting authorized refills, and do not confuse a lawful partial fill with a refill.
Reference: [1]
21. Noncontrolled refill authority
A refill is permission to dispense again under an existing prescription, so start with the prescriber's original authorization and the dispensing history. Confirm the patient, drug, strength, directions, quantity, issue date, and number of refills authorized. Then count refills already dispensed, including fills transferred to another pharmacy. For a noncontrolled drug, exhausted refill authority means the pharmacist must obtain further authorization before another dispensing, unless a separate, applicable emergency-supply provision permits a limited supply. A request for authorization should identify the existing order and what is being requested; document the prescriber's response before treating it as an additional refill or new prescription. A patient's continuing clinical need is a reason to seek continuity of care, but it does not amend the prescriber's order. Also distinguish an authorized refill from an early request that still needs clinical review.
Worked example: A noncontrolled prescription was written for 30 tablets with two refills. The original 30 tablets and both authorized refills have been dispensed, for three fills and 90 tablets total. The patient requests another 30 tablets. Zero refills remain, so the pharmacist seeks new prescriber authorization before dispensing, unless a separate applicable emergency-supply rule allows a limited supply.
Watch the distinction: A patient saying the medicine is taken indefinitely does not create unlimited refills. The prescriber's authorization and the recorded dispensing history determine what remains available.
Reference: [1]
22. Collaborative therapy authority
Guam's pharmacy practice rules describe initiating or modifying therapy under written guidelines or procedures approved for the pharmacist's practice by an authorized prescriber. Read such a document as a grant of specific authority. Identify the eligible patients and setting, covered drugs or classes, permitted actions, clinical conditions, required communication, and documentation. A dose adjustment, discontinuation, and initiation are distinct actions; permission for one does not imply permission for the others. Check whether the patient's findings meet the protocol's entry and exclusion conditions before acting. Record the findings, action, and required notification so another clinician can reconstruct the decision. The pharmacist must also have the professional authority and training applicable to the task. If a requested action falls outside the written boundaries, obtain an order from an authorized prescriber rather than stretching the protocol.
Worked example: A written protocol permits a pharmacist to adjust doses of an existing antihypertensive for enrolled patients after reviewing documented blood pressure readings. An enrolled patient meets those conditions, so the pharmacist may make and document a covered adjustment. The patient also asks to start a different drug class. That new therapy is outside the stated grant; the pharmacist refers that request to an authorized prescriber.
Watch the distinction: A protocol's broad treatment goal does not authorize every useful intervention. Its patient, drug, action, and documentation limits define the pharmacist's actual authority.
23. Orders in institutional care
An institutional medication order directs drug therapy within a facility's care process; a community prescription ordinarily supports dispensing a labeled supply to an individual. The settings differ, but neither removes the need to identify the patient, authorized practitioner, drug, dose, route, timing, and clinical purpose. In institutional care, verify the order against the active medication record, allergies, laboratory information when relevant, and the facility's rules for verbal, electronic, or standing orders. Clarify ambiguous abbreviations and conflicting orders before approval. A pharmacist performing remote medication order processing may evaluate and approve an order without physically dispensing the drug; the facility still controls storage, release, and administration. Guam's rules describe this separation for institutional remote processing. Treat an order as actionable only after the intended patient and the responsible prescriber are reliably established.
Worked example: A hospital pharmacy receives an electronic order for an antibiotic, but the patient field shows only a surname shared by two admitted patients. One has a documented allergy to that antibiotic. The pharmacist pauses approval, confirms the correct patient with the care team, then reviews that patient's allergy and order details. The order cannot safely be released on the surname alone.
Watch the distinction: A hospital order is not automatically valid because it came through a facility system. Patient identification, practitioner authority, and clinical review remain necessary.
24. Pharmacist administration of drugs
Administration places a drug into or onto a patient, which is a separate act from dispensing a product for later use. Guam's pharmacy practice definition includes administering therapy under written guidelines or procedures approved by an authorized prescriber, but the applicable authority must fit the particular drug, patient, and setting. Work through four questions: Is the pharmacist authorized for this category of administration? Does any required training or certification cover the technique? Is the patient eligible under the applicable order or protocol? Are documentation, observation, and response arrangements satisfied? Product handling and clinical assessment matter too: confirm identity, allergies, dose, route, expiration, and whether an acute concern calls for referral. Training demonstrates competence in a defined activity; it does not by itself enlarge legal scope. Keep the administration record separate from any record of product dispensing.
Worked example: A pharmacist trained for a specified vaccination service is asked to administer an unrelated injectable therapy. The drug has a different indication and procedure. The pharmacist checks the applicable Guam authority, prescriber order or written procedure, patient eligibility, and training for that therapy. Until those conditions are established, the pharmacist does not administer it or infer permission from vaccination training.
Watch the distinction: Experience with one injection technique does not authorize every injectable medication. The relevant authority must cover the drug, patient, action, and setting.
25. Delegated administration
Separate the steps around an administration visit before assigning them. Scheduling, assembling supplies, preparing a record, handling stock, assessing suitability, selecting a dose, giving the drug, and responding to a reaction can carry different legal and clinical responsibilities. A technician's permission to assist with preparation does not automatically extend to administration. For each step, determine whether Guam law allows that class of personnel to perform it in this setting, what training is required, and what kind of pharmacist supervision or verification applies. The pharmacist retains professional decisions such as resolving a contraindication and confirming the correct therapy. If a protocol authorizes an assistant's role, read its limits alongside the person's legal scope; a private protocol cannot grant power that law withholds. Document who performed the act, what was administered, and any required oversight.
Worked example: During an administration appointment, a technician retrieves the product and sets out supplies while the pharmacist verifies the patient, order, and allergy history. The patient then asks the technician to give the injection because the pharmacist is busy. The technician pauses. Supply preparation did not establish authority to administer; that act requires its own applicable authorization, training, and supervision conditions.
Watch the distinction: Being present during administration, or preparing its supplies, does not make a technician an authorized administrator. Evaluate the physical act and legal role separately.
Reference: [1]
26. Offering patient counseling
The MPJE competency statements include counseling and offering to counsel because the two acts differ. An offer gives the patient a real opportunity to speak with a pharmacist about the medication. Printed information can support that conversation, but handing over a leaflet alone does not show that the opportunity was offered. Identify the transaction and patient circumstances that trigger the applicable counseling requirement, then make the offer in a way the patient can understand and act on. If the patient accepts, the pharmacist should address the therapy's important use and safety questions. If the patient declines, respect the choice and record it accurately when documentation is required. A clerk may facilitate contact, but questions requiring professional judgment belong with the pharmacist. Language, privacy, and accessibility can determine whether the opportunity is meaningful.
Worked example: A patient picking up a first prescription receives a printed information sheet. At pickup, the pharmacist offers to discuss how to take the drug, expected effects, and important precautions. The patient asks whether it may be taken with a current medicine, and the pharmacist reviews the combination. The leaflet supplemented counseling; it did not replace the offer or the pharmacist's answer.
Watch the distinction: Placing a leaflet in the bag does not prove that counseling was offered. The patient needs an understandable chance to speak with a pharmacist.
Reference: [1]
27. What counseling should resolve
Useful counseling converts a verified order into a plan the particular patient can follow safely. Start with what the drug is for, the dose, route, timing, and duration. Then prioritize risks that change behavior: important interactions, activities to avoid, expected effects versus warning symptoms, missed-dose handling, storage, and any monitoring or follow-up. Use the patient's current medicines, conditions, habits, and ability to follow directions to decide what deserves emphasis. For an interaction, explain the practical consequence and the action to take, rather than merely naming the interacting substance. Avoid giving an unverified drug-specific instruction when the product or patient facts are unknown. Ask the patient to restate the key plan in their own words; this can reveal confusion that a simple “Do you understand?” misses. Document significant interventions and prescriber contact when appropriate.
Worked example: A patient starting a medication that can cause sedation reports drinking alcohol most evenings and driving to work early. The pharmacist explains that alcohol can add to impairment, advises avoiding the combination, and discusses how to follow the prescribed schedule safely. The patient repeats the plan and agrees to avoid alcohol while using the drug, then asks which symptoms should prompt a call.
Watch the distinction: Listing every possible adverse effect equally can obscure the main risk. Prioritize the facts that change this patient's use, monitoring, or need for help.
Reference: [1]
28. Recording counseling
A counseling record should describe what actually happened. Keep three events distinct: an offer was made, counseling occurred, or the patient declined the offer. If counseling occurred, record the material topics or intervention when required, especially a resolved misunderstanding, safety issue, or prescriber contact. If the patient refused, record the offer and refusal without implying that a full discussion took place. Capture enough context to identify the prescription, date, person involved, and pharmacist responsible under the applicable record rules. A checkbox can be useful only if its meaning is clear and staff use it consistently. The record supports continuity of care as well as later review; it should allow another pharmacist to see whether a risk was addressed or remains unresolved. For practice, distinguish those outcomes in MPJE Guam practice questions.
Worked example: At pickup, the pharmacist offers counseling on a new prescription. The patient says they cannot stay and declines. The record identifies the prescription and encounter, then states that counseling was offered and declined. It does not list drug risks as discussed. If the patient later calls with a question, that separate conversation can be documented on its own merits.
Watch the distinction: An offered discussion is not a completed discussion. Recording “counseled” after a refusal misstates the encounter and can hide an unresolved information need.
Reference: [1]
29. Confidential pharmacy records
Pharmacy records contain treatment details that should be accessible to people who need them for an authorized task. Match each worker's access to the work being done: a pickup clerk may need identity and transaction information, while a pharmacist reviewing therapy needs the clinical profile. Use individual system accounts, appropriate permissions, secure screens and paper records, and conversations that cannot easily be overheard. Confirm the recipient before discussing a patient's information by phone or electronic message. A familiar coworker, family member, or employer does not gain unrestricted access merely by asking. When an access request seems legitimate but its purpose is unclear, establish who is requesting the information and why before disclosing it. Guam's rules include patient privacy in the remote medication processing framework; the same practical principle applies when records move between sites or systems.
Worked example: A clerk preparing a prescription pickup sees the patient's name, order status, and amount due. The clerk asks to open the full clinical profile to learn the diagnosis out of curiosity. That information is unnecessary for the pickup task, so access is denied. The pharmacist may still review the profile for an interaction or counseling question connected to the prescription.
Watch the distinction: Employment at the pharmacy does not create a need to see every record. Access follows the person's authorized duty and the information needed to perform it.
30. Permitted health information sharing
When information leaves the pharmacy, first identify the recipient, purpose, and data requested. A treating clinician may need medication history to make a care decision; a payer may need specified information for payment; other uses may require patient authorization or another legal basis. Determine which rule applies before assuming all requests are equivalent. Share information relevant to the permitted purpose, verify the recipient's identity and secure destination, and record the disclosure when required. The patient may have rights to access their own record, but a person claiming to act for the patient needs verified authority. Urgency does not erase identity checks, though an applicable emergency provision may change the permissible pathway. For remote order review or care across settings, protect the electronic transmission as carefully as an in-person discussion.
Worked example: A hospital clinician calls for a patient's current medication list to reconcile treatment. Pharmacy staff verify the clinician and treatment connection, then provide the relevant list through an appropriate channel. An unrelated employer calls for the same patient's medication history to assess attendance. Staff do not treat that request as treatment and seek a valid legal basis before any disclosure.
Watch the distinction: A request sounding useful to someone else is not automatically a permitted disclosure. The recipient's role and purpose determine the applicable privacy pathway.
31. Returns, reuse, and redispensing
The central question for reuse is whether the pharmacy can establish both legal permission and product integrity. An uncollected prescription that remained under pharmacy control may be eligible for return to stock after checking seal or container condition, storage, expiration, lot information when relevant, and the accuracy of inventory and dispensing records. A product taken home has a different history: storage, tampering, contamination, and identity may be uncertain even if the package looks intact. Do not treat a refund or return transaction as proof that a drug may be redispensed. Controlled substances and temperature-sensitive products add distinct restrictions and documentation concerns. Work in sequence: determine custody, inspect and verify integrity, apply the relevant Guam and federal reuse rules, then document the disposition. If a condition cannot be established, keep the product out of usable inventory.
Worked example: One sealed prescription remains in a secured pharmacy bin because the patient never picked it up. Another sealed carton was taken home for a week and returned. Staff verify the first product's custody, condition, and records before considering return to stock. They segregate the second carton for disposition because its time outside pharmacy control prevents the same integrity conclusion.
Watch the distinction: An unopened appearance does not prove safe redispensing. Custody and storage history matter, and a product that left pharmacy control needs separate legal and integrity analysis.
Reference: [1]
32. Controlled drug disposal
Controlled drug disposal depends on who owns or possesses the drug and how it entered the pharmacy. Unusable controlled stock in pharmacy inventory follows the registrant's lawful disposal or reverse-distribution process, with records that reconcile the quantity removed. A patient's dispensed medication is no longer ordinary pharmacy inventory. Accepting it for disposal requires an authorized collection pathway; staff should not mix it into stock or treat its return as a dispensing reversal. If the pharmacy does not operate such a pathway, direct the patient to an authorized collection site or other permitted disposal method. Separate the safety advice from the legal transaction: the patient needs a practical way to prevent accidental ingestion or diversion, while the pharmacy needs an accurate chain of custody. Document any controlled stock movement according to its actual nature.
Worked example: A patient brings 18 unused controlled tablets to a pharmacy that has no authorized collection program. Staff do not add the 18 tablets to inventory, accept them as a routine return, or redispense them. They explain an authorized disposal option. Separately, the pharmacy's own expired controlled stock is handled through its documented registrant disposal process.
Watch the distinction: A patient return is not the same as pharmacy inventory disposal. The drug's ownership and custody determine which collection, transfer, and record rules apply.
Reference: [1]
33. Safety oversight and reporting
Different events call for different safety paths. A recall concerns a product or lot: identify affected stock, quarantine it, trace any dispensing, and follow the recall's notification and disposition instructions. A suspected controlled substance loss or diversion calls for prompt fact preservation, inventory reconciliation, investigation, and any required report to the appropriate controlled substance authority. A dispensing error requires immediate patient-safety action, documentation, and the applicable internal or external reporting process. A suspected adverse drug reaction may belong in a drug-safety reporting system, while a professional practice complaint may concern the Guam Board. Avoid treating one report as a substitute for another. For every event, preserve product identity, lot or prescription details, dates, quantities, involved people, actions taken, and unresolved facts. Report what is known and distinguish it from inference.
Worked example: A pharmacy receives a recall for one lot and also discovers a discrepancy in controlled stock. It quarantines the matching recalled bottles, checks which patients received that lot, and follows the recall directions. It separately recounts the controlled drug, preserves transaction records, investigates the discrepancy, and makes any required controlled substance report. Neither event is closed by documenting the other.
Watch the distinction: Sending a single generic safety report does not resolve every event. Recall, diversion, adverse reaction, and practice concerns have different evidence and reporting routes.
Reference: [1]
Dispensing Requirements
34. Legitimate medical purpose
A formally complete prescription can still be invalid if it was not issued for a legitimate medical purpose within the prescriber's usual professional practice. For controlled substances, the pharmacist has a corresponding responsibility to assess that question before dispensing. Look at the whole pattern: patient identity, clinical context, prescriber authority, drug and quantity, timing, travel or multiple-prescriber history, and explanations for unusual facts. A warning sign prompts investigation; it is not a diagnosis of misconduct. Ask targeted questions, use available records, contact the prescriber when needed, and document how concerns were resolved. An apparently ordinary prescription also needs review if other facts conflict. The decision is whether the pharmacist can establish a valid therapeutic basis and comply with applicable restrictions, not whether the paper looks convincing or the patient seems trustworthy.
Worked example: Four patients arrive close together with identical controlled prescriptions from one prescriber, each for the same dose and quantity. Their records show different conditions, and no documented reason explains the uniform orders. The pharmacist verifies identities and prescriber authority, reviews available histories, and seeks clinical clarification. Dispensing waits until the pattern has a credible, documented explanation for each patient.
Watch the distinction: A signature and all required fields do not prove legitimate medical purpose. The pharmacist must resolve material facts that cast doubt on the order.
Reference: [1]
35. Resolving warning signs
A warning sign is information that needs an answer before the dispensing decision. First specify the concern, such as a dose inconsistent with prior therapy, duplicate treatment, suspicious timing, or an unclear diagnosis. Then gather relevant facts from the patient profile, prescription monitoring information when applicable, the patient, and the prescriber. Evaluate whether the explanation addresses the actual concern; a prescriber's confirmation of authorship alone may not explain a clinically implausible dose. Record whom you contacted, what was learned, any change to the order, and why dispensing was or was not appropriate. If the concern remains unresolved, hold the prescription and explain the next step to the patient without making unsupported accusations. Corresponding responsibility requires professional judgment, so neither automatic refusal nor automatic acceptance is a substitute for investigation.
Worked example: A patient previously received a low dose, but a new controlled prescription specifies a substantially higher dose. The pharmacist checks the profile, confirms no transcription error, and calls the prescriber. The prescriber explains a documented titration and confirms the intended directions. The pharmacist records the discussion, assesses remaining safety concerns, and dispenses only after the increased dose is clinically and legally supported.
Watch the distinction: A brief note saying “doctor verified” may leave the warning sign unresolved. Document the reason the unusual fact is acceptable and any order change.
Reference: [1]
36. Transferring a noncontrolled prescription
A transfer moves usable prescription information and remaining authority from one pharmacy's record to another under the applicable rules. For a noncontrolled prescription, identify the original order, the patient's request, the permitted transferring personnel, the sending and receiving pharmacies, and the number of refills remaining. The receiving pharmacy must obtain reliable information directly through an authorized process and make a record sufficient to dispense correctly. The sending pharmacy must mark its record to prevent the same remaining fill from being used again. Check whether a prescription already filled, canceled, expired, or exhausted still has authority to transfer. Electronic records can simplify communication but do not excuse reconciliation. Treat a transfer as a controlled movement of authorization, not as a new prescription or an informal copy of the label.
Worked example: A noncontrolled prescription has one refill remaining at Pharmacy A. The patient asks Pharmacy B to fill it. Authorized personnel complete the transfer, B records the original order and one remaining refill, and A updates its record to show that authority moved. The patient cannot then obtain the same refill at A; a duplicate claim would trigger reconciliation before dispensing.
Watch the distinction: Giving the receiving pharmacy a photo of the old label does not by itself transfer refill authority. Both pharmacies must complete the authorized communication and records.
Reference: [1]
37. Controlled prescription transfers
For controlled prescriptions, first classify the proposed movement: is an unfilled electronic prescription being transferred for its initial filling, or are remaining refills on an already filled prescription being transferred? Different federal conditions apply, and the drug's schedule matters. The federal pathway for transferring an electronic controlled prescription for initial filling is distinct from rules governing refill transfers for eligible schedules. Verify that both pharmacies can complete the transaction within the required electronic and record process, that the prescription remains unfilled where required, and that Guam law permits the action. A Schedule II prescription has no refills to transfer. Do not infer a Guam answer from another jurisdiction's practice; a Hawaii MPJE guide concerns different local law. Record the transfer and ensure only one pharmacy can dispense under the moved authority.
Worked example: A patient asks to move an unfilled electronic Schedule II prescription from Pharmacy A to Pharmacy B. The pharmacists first confirm that it is still unfilled, that the electronic transfer pathway and both systems meet applicable conditions, and that Guam imposes no conflicting restriction. If those checks pass, they transfer for initial filling with the required records. They do not describe it as transferring a refill.
Watch the distinction: Rules for transferring remaining Schedule III through V refills do not automatically govern an unfilled electronic Schedule II order. Classify the transaction before applying transfer rules.
Reference: [1]
38. Allergy and contraindication review
A prospective review should separate three kinds of warning. A true allergy is an immune reaction, potentially serious even at a small dose. A predictable adverse effect, such as nausea, may still matter but does not automatically rule out the drug. A contraindication is a patient condition or concurrent therapy that makes use inappropriate or calls for a specific risk decision. Clarify the recorded reaction, timing, severity, drug identity, and any tolerated related products. Then compare the new drug with the implicated agent and assess whether the proposed use creates the same risk. Do not silently delete an allergy because the entry is vague; refine it and document the basis. For a plausible severe reaction, withhold release while contacting the prescriber and arranging a safe alternative or a justified, documented plan.
Worked example: The profile says “anaphylaxis” after a drug in the same family as a newly ordered antibiotic. The pharmacist asks what happened, confirms rapid breathing difficulty and emergency treatment, and checks whether the new drug shares the relevant risk. The pharmacist holds the order and contacts the prescriber for an alternative or a documented specialist-supported plan before dispensing.
Watch the distinction: Calling every unpleasant effect an allergy can block useful treatment, while dismissing anaphylaxis as a side effect can expose the patient to serious harm.
39. Dose, route, and duplicate therapy
Dose review asks whether the amount, frequency, route, and duration fit the patient and the drug. Examine age, organ function when relevant, indication, prior therapy, formulation, and any recent dose change. Route matters because oral and injectable products can have different onset, exposure, and administration requirements even when the active ingredient matches. Duplicate orders may represent an intentional transition, loading sequence, or combination, but they can also cause two doses to be given. Compare start and stop times, medication administration records, and prescriber notes before deciding. If the intent remains unclear, ask which order is active and whether one replaces the other. Document the clarification and update the record so dispensing and administration staff see one coherent plan. Guam's drug regimen review definition expressly includes dose, route, and duplicate therapy.
Worked example: A patient has an active oral order for a drug, and an injectable order for the same active ingredient arrives with no stop date. The pharmacist checks administration timing and contacts the prescriber. The prescriber confirms that the injection replaces the oral dose starting tonight. The oral order is discontinued in the active record before both forms can be supplied or administered.
Watch the distinction: Matching ingredient names do not prove that two routes are interchangeable or that both orders should remain active. Confirm the intended sequence and timing.
40. Interactions and use patterns
Interaction review combines mechanism with actual exposure. Check whether two drugs, a drug and food, or a drug and alcohol overlap at a time and dose that could matter; then consider the patient's conditions and monitoring. Utilization patterns add another clue. Compare quantity dispensed with intended daily use and elapsed time, but treat refill dates as estimates because stockpiling, hospitalization, dose changes, and use as needed can distort them. A late refill may indicate missed doses, stopped therapy, or surplus; an early request may reflect overuse or a legitimate change. Ask the patient how the medicine is actually taken before labeling the pattern. Where a meaningful interaction or use problem is found, explain the consequence, coordinate any needed prescriber change, and record the resolution. Guam's drug regimen review definition includes drug interactions, food interactions, overuse, and underuse.
Worked example: A prescription directs one tablet daily, and 30 tablets should last 30 days. The patient reports that a 30-tablet fill lasted 60 days, an average of 30 ÷ 60 = 0.5 tablet per day, or half the intended daily use. The pharmacist asks about missed doses, hospitalization, and changed directions before judging adherence or treatment response.
Watch the distinction: A refill interval alone cannot prove nonadherence. Calculate the apparent use, then check dose changes, extra supply, and the patient's account before interpreting it.
41. Prescription monitoring data
A prescription monitoring program has two distinct functions: showing reported dispensing history to an authorized user and receiving a report after a covered drug is dispensed. A query helps the pharmacist assess a pending prescription; it is not evidence that the pharmacy has reported its own later dispensing event. Read a result as a lead for investigation. Match patient identifiers, drug, fill date, quantity, prescriber, and pharmacy before drawing conclusions. Reporting delays, identity errors, and care at another pharmacy can explain an apparent discrepancy. A recent fill may also represent a legitimate therapy change. Ask the patient about the history, examine the clinical context, and resolve material concerns before deciding whether to dispense. The MPJE competency statements identify both accessing and reporting monitoring data as dispensing topics.
Worked example: A Guam pharmacist sees a controlled drug fill dated three days earlier that the patient did not mention. The pharmacist confirms the identifiers and contacts the listed pharmacy to check whether the entry belongs to this patient and was actually dispensed. The patient explains a therapy switch; the prescriber confirms it. The pharmacist documents those findings and assesses the new order on its merits. Any required report follows dispensing.
Watch the distinction: A monitoring entry is not automatic proof of misuse. Treating an unexplained fill as a final verdict skips identity checks, reporting context, and the pharmacist's clinical assessment.
Reference: [1]
42. Early refill requests
An early refill request is a warning sign that starts a review, not a universal prohibition or permission. First establish what the original order authorizes and whether any refills remain. Then identify the drug's schedule, the last dispensing date, quantity, directions, and expected days of use. Compare the expected supply with the request date, accounting for documented dose changes, lost medication, travel, or other explanations. For controlled drugs, assess legitimacy and any applicable federal and Guam restrictions; a payer's willingness to cover a claim does not establish legal authority. Discuss an unexplained pattern with the patient and, when needed, the prescriber. Record the facts and the reason for the decision. A single early request can have several explanations, while repeated requests can change the significance of an otherwise plausible account.
Worked example: A patient requests a 30-day supply ten days before the prior supply should end, citing travel. The record shows a prior fill of 30 tablets with directions for one daily, so about ten tablets should remain if taken as directed. The pharmacist verifies an unused authorized refill, checks the drug's restrictions, confirms the travel dates and use history, and resolves any concern before dispensing or declining.
Watch the distinction: Travel does not create refill authority. Conversely, the calendar alone does not prove misuse; the pharmacist must reconcile authorized refills, actual use, the drug's restrictions, and the explanation.
Reference: [1]
43. Emergency supply when refills run out
When a patient has no refills, distinguish three possible sources of authority: an existing refill that was overlooked, a new prescriber authorization, or an applicable emergency supply provision. Clinical urgency by itself does not add a refill to the original order. For a possible emergency supply, identify the medicine, the patient's established therapy, the risk of interruption, attempts to reach the prescriber, and whether the governing Guam rule covers that drug and setting. If an exception applies, its conditions control the amount and required notice or records. Controlled substances can have separate restrictions, so do not assume a rule for maintenance medicine extends to them. Document the unavailable prescriber, the legal basis used, the quantity supplied, and follow-up. If no authority applies, help arrange prompt evaluation or prescriber contact.
Worked example: A patient has used the same maintenance medicine for months, but the prescription has no remaining refills. The prescriber cannot be reached that evening. The pharmacist confirms the prior order and assesses the harm of interruption, then checks whether current Guam law permits an emergency supply for this medicine. If it does, the pharmacist follows its conditions and records the basis and quantity; otherwise, no supply is issued without authorization.
Watch the distinction: An urgent need is a clinical fact, not a free-standing dispensing authorization. A pharmacist must connect any emergency supply to an applicable legal exception and satisfy its conditions.
Reference: [1]
44. The dispensed prescription label
The dispensing label is the patient's operating instruction for the product actually supplied. Compare it against the verified prescription and the selected container, not merely against a technician's entry. Check patient identity, drug name and strength, dosage form, directions, quantity, and the required pharmacy and prescriber information. Translate approved directions into clear patient language without changing dose, route, frequency, or duration. If the order says two doses daily, a label saying one daily can halve intended use even when the bottle contains the right tablets. Auxiliary warnings can clarify safe use but cannot repair an incorrect primary direction. After a correction, recheck the printed label, stock container, and contents together. The pharmacist's final review should catch discrepancies before release, including labels generated from old profile defaults.
Worked example: A verified order calls for one tablet twice daily and 60 tablets. The bottle contains 60 correct tablets, but its label says one tablet daily. At the printed rate, 60 tablets would last 60 days; at the ordered rate, they last 30 days. The pharmacist corrects the directions, prints a new label, and checks it against the order and contents before release.
Watch the distinction: A correct drug in the bottle does not make an incorrect label harmless. The patient may follow the label, so directions and product must agree with the verified order.
Reference: [1]
45. Packaging for safe use
Packaging must preserve the medicine and make its use reasonably safe. Begin with the manufacturer's storage information: moisture, light, temperature, and container requirements can determine whether the original package should remain intact. Then consider closure requirements, including child-resistant packaging where applicable, and whether a lawful exception has been requested or otherwise applies. An easy-open request does not eliminate stability needs; the pharmacist may need another compliant container or a different dispensing approach. Unit-dose packaging also needs an appropriate identity, lot, and dating trail when repackaging is allowed. Do not assign a new beyond-use date simply from the original expiration date without considering the repackaging process and applicable standards. The final check asks whether the chosen container protects the product through its intended use and gives the patient usable directions.
Worked example: A moisture-sensitive medicine arrives in a protective blister pack. A patient asks for the tablets in an easy-open bottle. The pharmacist checks the product's packaging instructions and finds that transferring the tablets would compromise the required protection. The pharmacist keeps the protective package and assesses a lawful way to meet the patient's access need, explaining how to store and use the medicine.
Watch the distinction: A patient's container preference does not establish that repackaging is safe. Child-resistant closure rules and product stability are separate questions, and both must be resolved.
Reference: [1]
46. Products that must not be dispensed
A product can be unsuitable for dispensing even when its label and appearance seem normal. Check expiration and recall status, package integrity, evidence of contamination or tampering, and whether storage conditions were maintained. An undocumented temperature excursion creates uncertainty about potency; appearance cannot establish chemical stability or sterility. Segregate affected stock so it cannot be selected accidentally, preserve lot and storage records, and determine its disposition using reliable product information and applicable requirements. A recall may apply only to specific lots or presentations, so match identifiers before removing or releasing stock. If a damaged package exposes the contents, treat it as a product integrity issue rather than a cosmetic defect. Replacement stock should undergo the same identification and storage checks before the prescription is completed.
Worked example: A refrigerated product is found on a counter after a shift change, and no one can establish how long it was outside its required range. The pharmacist marks the affected lot unavailable, checks available temperature records and product guidance, and seeks a supported disposition. Because the excursion cannot yet be evaluated, the pharmacist fills the prescription from verified stock rather than relying on the product's normal appearance.
Watch the distinction: Clear liquid and intact packaging do not prove retained potency after improper storage. Quarantine preserves the option to investigate without exposing a patient to uncertain stock.
Reference: [1]
47. Nonprescription product controls
Nonprescription status does not mean every sale follows the same path. Classify the product and transaction first: an ordinary shelf item, a product kept behind the counter, a drug with identity or quantity controls, or a hazardous product requiring special handling. For a restricted sale, determine who may furnish it, what eligibility checks and transaction records apply, and whether the requested quantity is allowed under the governing rule. Separately assess whether the patient's symptoms, other medicines, or intended use call for pharmacist counseling or referral. A product's location in the store is a clue about workflow, not a legal classification. Packaging and labeling requirements still apply when a nonprescription item is repackaged or supplied outside its original container. Staff should complete required checks before transferring possession.
Worked example: A customer asks for two packages of a product stored behind the counter. The pharmacist identifies the product's applicable purchase controls and checks the customer's eligibility, requested total quantity, and required record before sale. The pharmacist also asks about intended use and other medicines. If the legal checks cannot be completed, the sale waits even though the product does not require a prescription.
Watch the distinction: Behind-the-counter placement is not itself a complete rule. The actual product category determines the identity, quantity, record, and counseling steps that govern the transaction.
Reference: [1]
Pharmacy Operations
48. Authorized drug suppliers
Purchasing starts with the seller's authority and the product's path into legitimate commerce. Verify that the proposed supplier holds the permissions appropriate to the drugs and transaction, then compare its business identity with the invoice, shipping information, and traceability documents. For controlled stock, check the additional registration and ordering conditions that apply. For other prescription stock, inspect transaction history and product identifiers as required by applicable distribution rules. A low price or familiar brand name cannot substitute for provenance. On arrival, hold goods that have inconsistent lot data, suspicious packaging, unexplained source changes, or missing documentation until resolved. Keep the records that connect the supplier, shipment, product, and receipt, since those links allow later recall response and diversion investigation. The Guam MPJE practice questions can help you rehearse that decision sequence.
Worked example: An unfamiliar seller offers discounted prescription stock. The pharmacy verifies the seller's authority, checks that the invoiced company matches the actual shipper, and examines the product traceability records before purchase. One proposed lot lacks a coherent transaction history, so the pharmacy declines that lot and records the discrepancy. The discount does not establish that the supply chain is legitimate.
Watch the distinction: A professional-looking invoice is evidence of a claimed sale, not proof that the seller is authorized or that the specific drug followed a legitimate distribution path.
Reference: [1]
49. Receiving and reconciling stock
Receiving is a three-way comparison among what was ordered, what the supplier billed, and what physically arrived. Count packages using the correct unit, then check drug, strength, dosage form, lot, expiration, seal, and storage condition. A case count can conceal a shortage if package sizes differ, so translate units before posting inventory. Record the amount actually accepted; preserve the invoice and note any back order, damage, or shortage separately. Investigate a mismatch with the supplier and, for controlled drugs, follow the additional acquisition record process. Do not place questionable stock into usable inventory while its identity or integrity is unresolved. This approach creates an audit trail that explains both the financial claim and the physical movement of medication without changing a number merely to make the ledger balance.
Worked example: A purchase order and invoice each list 24 bottles of 100 tablets, but staff count 23 sealed bottles. The expected quantity is 24 × 100 = 2,400 tablets; the received quantity is 23 × 100 = 2,300 tablets. The pharmacy records 23 bottles received and a shortage of one bottle, or 100 tablets, then seeks correction from the supplier before closing the discrepancy.
Watch the distinction: Entering the invoiced amount as received creates 100 tablets of phantom stock in this example. Inventory must reflect verified physical receipt, with the billing difference tracked separately.
Reference: [1]
50. Schedule II ordering records
Schedule II acquisition requires an authorized ordering pathway and a record that connects the order to what actually arrived. Federal practice uses a compliant paper order or approved electronic ordering system; the specific method must fit the buyer, supplier, and transaction. The order states the intended items and quantities. Receiving staff then verify product, package size, and quantity delivered, record the receipt information required for that pathway, and investigate any shortage or substitution. An unfilled part of an order is not inventory on hand. Retain the order, supplier documents, and receipt record so an auditor can trace each package from acquisition into later inventory movements. In a question, identify whether a number represents units ordered, units shipped, or units physically received before performing any reconciliation. The MPJE study guide provides related jurisprudence practice.
Worked example: A pharmacy places an authorized order for five packages of a Schedule II drug, with 100 tablets per package. Four correct packages arrive. The intended order is 500 tablets; verified receipt is 4 × 100 = 400 tablets, leaving a shortage of 100 tablets. Staff record four packages as received, retain the ordering trail, and investigate the missing package rather than adding 500 tablets to stock.
Watch the distinction: An authorized order documents a request, not physical possession. Posting all five packages before verifying delivery would overstate controlled inventory by one package, or 100 tablets here.
Reference: [1]
51. Distribution and reverse distribution
Classify an outgoing movement before choosing its record. Dispensing supplies medication pursuant to a patient-specific order. Distribution transfers stock to an authorized recipient for its own lawful use or supply chain role. Reverse distribution sends unusable or unwanted stock through an authorized process for return, credit, or disposal; it is not a patient fill. Controlled substances can require additional transfer and destruction documentation, so identify the drug's schedule and each party's authority before shipment. Record the product, strength, package quantity, lot when relevant, sender, recipient, date, and disposition pathway needed to reconstruct the movement. Remove shipped units from on-hand inventory using the actual quantity transferred. A patient returning a dispensed product presents a different issue from a pharmacy transferring its own stock to a reverse distributor.
Worked example: A pharmacy has three expired bottles of a controlled drug, each containing 50 tablets. It verifies an authorized reverse distributor and ships the sealed bottles through the proper process. The outgoing inventory movement is 3 × 50 = 150 tablets. Staff record the recipient, shipment, and required disposition documents. They do not enter 150 tablets as patient dispensing or place them back into usable stock.
Watch the distinction: Every outgoing controlled drug is not a dispensing event. The recipient and purpose determine whether the movement is patient supply, stock distribution, or reverse distribution.
Reference: [1]
52. Controlled substance inventory
Inventory reconciliation compares a physical count at a defined time with a record-derived expected balance. Calculate expected on-hand units as opening count plus receipts and documented returns, minus dispensing, authorized transfers, and other supported removals. Use one unit throughout: bottles must be converted to tablets before comparing them with tablet dispensing entries. Count carefully and review transactions around the cutoff time, since a sale entered after the count can create an apparent difference. If the numbers still disagree, investigate receipt errors, package size mistakes, reversed transactions, breakage, and possible diversion. Preserve the original count and corrections with dates and explanations; changing a record to force agreement destroys the trail. Controlled substance inventory duties also include prescribed timing and record content under applicable law, separate from the arithmetic used to detect a discrepancy.
Worked example: The opening balance is 100 tablets. The pharmacy receives 50 and dispenses 30, so expected stock is 100 + 50 − 30 = 120 tablets. A physical count finds 116. The shortage is 120 − 116 = 4 tablets. Staff recount, check package sizes and transactions through the count time, and document the unresolved difference for further investigation.
Watch the distinction: A four-tablet difference should not be erased with an unsupported adjustment. Reconciliation identifies a question; it does not establish whether the cause is a recording error or loss.
Reference: [1]
53. Records that reconstruct a transaction
A useful pharmacy record lets a reviewer reconstruct who authorized a transaction, what product moved, when it moved, and why the inventory changed. Link the original prescription or order to clarifications, final dispensing data, product identifiers, acquisition records, returns, and corrections. For a controlled drug, those links are particularly important when comparing acquisition and disposition. Audit trails should preserve the original entry and show who made a later correction, rather than silently replacing history. A discrepancy may come from a second prescription, a documented transfer, a damaged product, or a data entry error. Trace each plausible movement using source documents and time stamps before deciding which entry needs correction. Record retention and access rules govern how long these materials remain available and who may inspect them.
Worked example: The dispensing log shows 60 tablets supplied, while inventory fell by 90 tablets during the same interval. The unexplained gap is 90 − 60 = 30 tablets. Staff find a separately documented 30-tablet transfer to an authorized facility and match its date and product. The records now explain the full 90-tablet decrease without changing the 60-tablet patient dispensing entry.
Watch the distinction: Making the dispensing figure equal the inventory decrease would misstate what the patient received. First identify each separate movement and preserve the record supporting it.
Reference: [1]
54. Drug storage and staff access
Storage controls protect both access and product quality. Identify the professional service area, who may enter it, and which drugs require particular temperature, light, or security conditions. When a pharmacist is absent, Guam's published pharmacy rules describe a secured, locked barrier for a pharmacy that continues operating as a nonprescription or sundry outlet. That barrier prevents unlicensed staff from reaching prescription stock; merely telling them not to enter is insufficient. During staffed hours, limit access according to each person's authority and assigned task. Monitor storage conditions and investigate excursions before releasing affected products. If an automated cabinet is involved, separate the cabinet's user permissions from the pharmacy's broader room security. A manager's responsibility for controls does not disappear when another pharmacist covers a shift.
Worked example: A Guam store stays open for sundries after its pharmacist leaves. Prescription stock and the dispensing counter remain inside the professional service area. Staff close and lock the approved barrier before the pharmacist departs, leaving sundry shelves accessible. A clerk cannot enter the secured area to retrieve a waiting prescription; the patient must return when authorized pharmacy service is available.
Watch the distinction: An open retail store does not mean the professional service area may remain accessible. Guam's published rule requires physical security when pharmacy service has ended.
55. Hazardous drug handling
Hazardous handling starts by identifying the product's hazard, then following its path from receipt through storage, preparation, administration support, spill response, and disposal. Exposure can occur through broken containers, contaminated packaging, powder, droplets, or waste, even when no dose is being compounded. Assign trained personnel and suitable protective equipment for the task; choose containment and cleaning methods that prevent spread rather than treating a spill as ordinary housekeeping. Segregate damaged stock so it cannot be selected for dispensing or mixed with standard returns. Document the incident, affected product, personnel exposure, and disposition as applicable. The exact controls vary by preparation and activity: opening a damaged package, counting intact tablets, and preparing an injectable dose do not present the same exposure route. Protecting the drug's integrity and protecting workers are simultaneous obligations.
Worked example: A carton of hazardous tablets arrives crushed, with powder visible inside the shipping box. Receiving staff stop handling it as ordinary stock, isolate the box, and notify personnel trained for the facility's spill procedure. Those personnel use the designated protective controls, document the affected lot and quantity, and arrange appropriate disposal or return. No tablets from that carton enter usable inventory.
Watch the distinction: A sealed outer shipping box does not make visible powder safe to handle casually. Hazard classification and the observed damage determine the response, even before compounding begins.
Reference: [1]
56. Delivery and chain of custody
Delivery extends the dispensing process beyond the counter, so the pharmacy must preserve identity, condition, and accountability until the intended recipient receives the package. Match the patient and address to the verified order before sealing a parcel; similar names are especially risky. Use packaging that protects confidentiality and any required temperature or physical condition during transit. Record when the parcel left, who carried it, where it was directed, and the evidence of delivery appropriate to the service. For a failed delivery, determine where the product was held and whether its integrity remains acceptable before another attempt. A courier's scan documents movement, not a pharmacist's clinical verification. The pharmacist's review and any required counseling arrangements should be completed through the applicable workflow before dispatch.
Worked example: Two prepared parcels are for Ana Cruz at one address and Ana Cruz at another. Staff compare each prescription number, patient identifier, and delivery address with its parcel before handing either to the courier. They find the address labels were swapped, correct them, and recheck both packages. The courier receives a traceable handoff only after the products and recipients match.
Watch the distinction: Matching a name alone is inadequate when names repeat. A delivery scan also cannot correct a parcel that was labeled for the wrong recipient before dispatch.
Reference: [1]
57. Generic and product selection
Product selection begins with the prescribed drug, strength, dosage form, and route. A proposed alternative may have the same active ingredient yet differ in release mechanism, delivery device, concentration, or route. Determine whether it is therapeutically equivalent for the intended substitution, then check the prescriber's instructions, patient needs, and Guam's applicable selection rules. A lower acquisition cost cannot override a prohibition or a clinically meaningful difference. When a substitution is allowed, ensure the dispensed label describes the product actually supplied and explain any change that could affect use. If the proposed product changes the therapy rather than providing an authorized equivalent, obtain a new prescriber decision. The key distinction is between selecting an interchangeable product within an authorized order and changing an element of the order that requires prescriber authority.
Worked example: An order specifies an immediate-release tablet. The available lower-cost product contains the same active ingredient and strength but is extended-release. Its release pattern differs, so the pharmacist does not substitute it on ingredient matching alone. The pharmacist obtains the prescribed formulation or asks the prescriber to authorize a therapy change. The patient's price concern informs that discussion but does not create substitution authority.
Watch the distinction: Same ingredient and strength do not guarantee the same therapeutic effect or lawful substitution. Dosage form and release characteristics can change how the drug works.
Reference: [1]
58. Compounding controls by preparation
A compounding request has two independent classifications. First decide whether the finished preparation must be sterile, based on route and intended use. Then determine whether any ingredient makes the work hazardous. The combination determines personnel training, workspace, protective equipment, handling methods, quality checks, and disposal. Sterility controls address microbial and particulate contamination of a preparation that enters a sterile body site. Hazardous drug controls limit exposure to workers and the environment. For a sterile hazardous injection, both sets operate together; a protective cabinet alone does not establish product sterility, and an aseptic technique alone does not control hazardous exposure. Confirm the formula, source ingredients, compatibility, container, labeling, and assigned beyond-use dating under the applicable standards before release. If the facility lacks a required capability, it should not prepare the item.
Worked example: A hospital requests a patient-specific injection containing a hazardous drug. The pharmacist classifies it as both sterile and hazardous. Trained staff use an environment and procedure suitable for aseptic preparation and hazardous containment, verify ingredients and calculations, and apply the required quality and labeling checks. A room equipped only for ordinary nonsterile mixing cannot satisfy the request.
Watch the distinction: Sterile and hazardous are separate attributes. Passing one set of controls does not cover the other, so a sterile hazardous injection needs both.
Reference: [1]
59. Central fill, automation, and remote review
A distributed pharmacy workflow divides work without removing accountability. Separate receipt and evaluation of the order, data entry, physical filling, storage, pharmacist approval, release, and administration. Guam's published rules define remote medication order processing for an institutional facility as pharmacist review and related order work; they distinguish that processing from dispensing. A remote pharmacist may evaluate and approve an order while medication remains at the Guam institution, but the physical system must still restrict stock access and record release. Identify the Guam facility, the remote site, and the pharmacists responsible for each stage. Automated storage can record selection and access, yet it cannot turn an invalid order into a valid one. Review the sequence and records so that a later auditor can tell who approved the order and who released the drug.
Worked example: After hours, a Guam institution sends an order to a contracted remote pharmacist. The pharmacist reviews the patient profile, clarifies a dose, and approves the corrected order. An automated cabinet at the institution then makes the identified medication available to authorized staff and records removal. Remote approval addresses the order; the cabinet's stock, access, release, and subsequent administration remain separately accountable steps.
Watch the distinction: Remote approval is not the same event as physical dispensing or administration. Treating one electronic approval as proof of every later step hides access and stock-control failures.
60. Pharmacy permits and inspection
A pharmacy permit attaches operating authority to a practice setting under stated conditions. Before opening, establish the owner, location, required application, inspection, and grant of authority. Guam's published rules state that a pharmacy may not operate before a permit is granted, that a permit applies to its designated location, and that a change in ownership requires reporting, return of the former owner's permit, and a permit for the new owner before operation. Ongoing authority also depends on applicable renewal, inspection, and compliance requirements. A pharmacist's personal license does not replace the business permit, and an existing permit does not automatically follow a sale or move. If the Board takes disciplinary action, read the actual order to determine its effect on operations. In a scenario, identify the entity, address, permit holder, and effective status before deciding whether service may continue.
Worked example: A permitted Guam pharmacy is sold, and the buyer plans to open under the former owner's permit while its own application is pending. The published ownership rule calls for reporting the change, returning the old permit, and obtaining a permit for the new owner before operating. A licensed pharmacist's presence does not cure the missing facility authority. The buyer opens only after the required permit is granted.
Watch the distinction: A pharmacy permit does not travel automatically with the shelves, staff, or trade name. Ownership and location are part of the authority that must be checked.
Official references and further reading
- Current MPJE competency statements (before March 2027)
- GUAM BOARD OF EXAMINERS FOR PHARMACY
- 25 GAR Ch. 13